TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT05904652

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Fisher and Paykel HealthCare Airvo™ 3 high flow system
Description: High Flow Nasal Oxygen Delivery Device

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Conventional Oxygen Therapy
Description: Low flow oxygen delivery device (Flow rate between 2 litres per minute and 15 litres per minute)
Study: NCT06509230

Intervention type: OTHER
Description: The fibrosis grades were grouped without drug intervention

Intervention type: OTHER
Description: The fibrosis grades were grouped without drug intervention

Intervention type: OTHER
Description: The fibrosis grades were grouped without drug intervention
Study: NCT05949021

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Combination of liposomal doxorubicin
Description: Combination of liposomal doxorubicin 30 milligrams per square meter and carboplatin (area under the curve 5), administered every 4 weeks for 4 cycles.
Study: NCT06059911

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Multi-ingredient dietary supplement (caffeine, creatine monohydrate, β-alanine, citrulline malate, BCAA)
Description: Administration of a multi-ingredient dietary supplement consisting of 200 mg caffeine, 3.3 g creatine monohydrate, 3.2 g β-alanine, 6 g citrulline malate and 5 g branched chain amino acids

Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo dietary supplement (97% maltodextrin)
Description: Administration of an isoenergetic placebo comparator dietary supplement consisting of 97% maltodextrin
Study: NCT05459103

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Bidirectional remote interaction intervention
Description: Intervention group participants engaged in a 12-week bidirectional remote interaction. All interactions were conducted through the same group on Line. A one-hour interactive online group intervention was held every Monday to Friday from 14:30 to 15:30, for a total of 60 hours. The online interactive interventions were conducted in a structured course format, with a facilitator conducting live classes and alternating between static and dynamic classes.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Unidirectional remote interaction intervention
Description: Control group participants engaged in a 12-week unidirectional remote interaction. All interactions were conducted through the same group on Line. Research assistants posted a YouTube video on the Line group at 14:30 every day, Monday through Friday, covering art, music, senior sports, long-term care resources, travel, and food preparation.
Study: NCT05678829

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Education
Description: The trainings for the Virtual Reality group will continue in accordance with the training titles according to the weeks, using virtual reality glasses.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Education
Description: The trainings for the Virtual Reality group will continue in accordance with the training titles according to the weeks, using virtual reality glasses.
Study: NCT05987709

Intervention type: DIAGNOSTIC_TEST
Group type: OTHER
Intervention: GuardantSHIELD Blood Test
Description: The GuardantSHIELD CRC screening test is a commercially available test which works by finding signs of colorectal tumor in the blood of patients at average risk for CRC
Study: NCT04487457

Intervention type: OTHER
Intervention: Blood samples
Description: Blood samples
Study: NCT06061068

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Hernia belt compression
Description: Use the hernia belt to compress the inguinal region
Study: NCT06319300

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: AI-assisted insulin dose adjustment model
Description: We use an artificial intelligence-assisted insulin dose adjustment system to adjust insulin doses in hospitalised patients

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: doctor's insulin dose adjustment
Description: participants' insulin doses are adjusted by doctors
Study: NCT05865548

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Aspirin 150 mg
Description: Aspirin 150 mg PO daily

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Standard of care
Description: Surgery with or without radiation, palliative chemo as per investigators choice
Study: NCT04784988

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: EHL-FVIII
Description: prophylaxis with EHL-FVIII targeting a 12% FVIII through level based on PK assessment with WAPPS-Hemo

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: FVIII concentrate
Description: standard prophylaxis with FVIII concentrate according to current guidelines
Study: NCT05995158

Intervention type: PROCEDURE
Intervention: Metagenomic testing of the subgingival plaque samples
Description: sampling, extraction and sequencing of the oral microbiome in the samples

Intervention type: PROCEDURE
Intervention: Metagenomic testing of the subgingival plaque samples
Description: sampling, extraction and sequencing of the oral microbiome in the samples

Intervention type: PROCEDURE
Intervention: Metagenomic testing of the subgingival plaque samples
Description: sampling, extraction and sequencing of the oral microbiome in the samples
Study: NCT05921019

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: laser acupuncture
Description: This study will use the Handylaser Trion laser manufactured by RJ Laser, Germany.

Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: sham laser acupuncture
Description: This study will use the sham Handylaser Trion laser manufactured by RJ Laser, Germany,and without any laser beam delivering
Study: NCT06140888

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ginkgo Biloba Extract
Description: Ginkgo biloba extract 8 pills three times per day is administrated.
Study: NCT04759768

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Nalmefene Hydrochloride
Description: 3mg nasal spray

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Nalmefene
Description: 1mg intramuscular injection
Study: NCT06364514

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Clinical Stability Assessment
Description: Base total days of antibiotics on clinical stability vs utilizing predetermined total days of antibiotics
Study: NCT06134557

Intervention type: PROCEDURE
Intervention: conventional stents
Description: performed the study to compare the safety and efficacy between flow diverters and conventional stents in IVADA patients undergoing endovascular therapy. Stent-assisted coiling is the preferred option for most surgeons. In addition,It is believed that dense packing is not necessary as long as the aneurysm neck is covered to isolate the dissection. How ever,whether it is really necessary to adjunct coil,and if it is necesary, what is the ideal packing density of coils, there is no clear conclusion at present.This study aimed to compare the safety and efficacy between flow diverter and conventional stents in patients with IVADA, determine the ideal packing density of coils after FD stent placement,and to observe the hemodynamic changes before and after the treatment of FD stent.

Intervention type: PROCEDURE
Intervention: conventional stents
Description: performed the study to compare the safety and efficacy between flow diverters and conventional stents in IVADA patients undergoing endovascular therapy. Stent-assisted coiling is the preferred option for most surgeons. In addition,It is believed that dense packing is not necessary as long as the aneurysm neck is covered to isolate the dissection. How ever,whether it is really necessary to adjunct coil,and if it is necesary, what is the ideal packing density of coils, there is no clear conclusion at present.This study aimed to compare the safety and efficacy between flow diverter and conventional stents in patients with IVADA, determine the ideal packing density of coils after FD stent placement,and to observe the hemodynamic changes before and after the treatment of FD stent.
Study: NCT05073822

Intervention type: DRUG
Group type: OTHER
Intervention: Tacrolimus
Description: reduction of both standard Tacrolimus \& Mycophenolate mofetil does in one arm

Intervention type: DRUG
Group type: OTHER
Intervention: Tacrolimus
Description: reduction of both standard Tacrolimus \& Mycophenolate mofetil does in one arm
Study: NCT05197452

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: COVID-19 Testing
Description: For in-person PCR testing, a nasal swab will be inserted shallowly into the participant's nose and rotated in each nostril. The swab will be broken off into a designated test tube and placed into a specimen bag along with a label. All specimens will be stored in a cooler until they are transported the Rush Laboratory for COVID-19 analysis.~For at home antigen testing, participants will download an app to their mobile phone and watch an informational video. The test will be self-administered by inserting a nasal swab into the nostril until a cap containing the swab touches the nose; rubbing the swab tip around the nose cavity 3 times; removing the swab and repeating in the other nostril. The nasal swab, a dropper, processing fluid, and a blue tooth connected analyzer are provided with the testing kit to analyze the sample for COVID-19. COVID-19 home test results are displayed on the participants smart phone after 15 minutes.
Study: NCT05482711

Intervention type: OTHER
Group type: OTHER
Intervention: Time Restricted Eating Intervention
Description: All participants will be asked to adhere to suggested fasting and feeding periods throughout the 8 week study period. These participants will self-monitor eating and sleeping habits as well to present to study staff at checkpoints. Self-reported information will be used during group-mediated intervention sessions throughout the duration of the study, as well.
Study: NCT00012688

Intervention type: DRUG
Group type: OTHER
Intervention: Doxycycline HCI 10mg po for 2 weeks

Intervention type: PROCEDURE
Group type: OTHER
Intervention: Ultrasonic scaling with 0.12% chlorhexidine gluconate
Study: NCT05391867

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lenvatinib
Description: Tyrosine kinase inhibitor

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lenvatinib
Description: Tyrosine kinase inhibitor
Study: NCT06509594

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Protocol of Scapular Stabilization Exercises;
Description: Exercise for the middle trapezius and rhomboid muscles: Participants were instructed to stand with their arms hanging beside their bodies. Then, they were instructed to flex their elbows 90◦ holding an elastic band and performing an external rotation of the shoulder, pulling both scapula together. Subsequently, they returned to a neutral shoulder position with elbow flexion.~Exercise for the lower trapezius muscle: Participants were instructed to lie down in a prone position while holding an elastic band attached at one end under a mattress. They were then instructed to raise their shoulder 140◦.~Exercise for the serratus anterior muscle: Participants were instructed to stand and flex their elbows 90◦ while holding an elastic band fixed behind the participants. Next, they were instructed to move the arm forward with a protracted scapula.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Protocol of Muscle Energy technique;
Description: During upper trapezius stretching, the participants were in seated position by holding the chair with one arm, and laterally tilted the head to the opposite side with the other hand pushing the head to increase lateral stretch.~For pectoralis muscle stretch, participants were asked to stand in front of the Doorframe with elbow bent at 90 degree and was asked to lean forward without Taking a step forward. The stretch is felt across the anterior chest, which is held for 15-30 seconds with 2-3 repetitions. For levator scapulae stretch, the subjects were asked to take the seated position while holding the chair with one hand in order to maintain shoulder depression, then To flex and rotate neck to the opposite side by placing the other hand at the back of their head and to slowly pull it down toward the armpit.
Study: NCT05067582

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: L1-79
Description: tyrosine hydroxylase inhibitor
Study: NCT04755309

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Rhythmic intervention
Description: The rhythmic intervention consists in an ecological and non-invasive intervention based on enriched auditory and musical active experience. It is based on the most recent scientific evidence in the field and provides exposure to and active synchronization with complex musical rhythms. It is thought to promote the infant's ability to recognize and process the complex rhythms of spoken language. Importantly, it taps into and empowers early auditory processing skills. The intervention includes several tasks described in the literature, for example tapping and bouncing at the beat of complex musical rhythms.~The intervention takes place in small groups of infant-caregiver pairs (N=4/5) for 1 hour/week for 6 weeks.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Rhythmic intervention
Description: The rhythmic intervention consists in an ecological and non-invasive intervention based on enriched auditory and musical active experience. It is based on the most recent scientific evidence in the field and provides exposure to and active synchronization with complex musical rhythms. It is thought to promote the infant's ability to recognize and process the complex rhythms of spoken language. Importantly, it taps into and empowers early auditory processing skills. The intervention includes several tasks described in the literature, for example tapping and bouncing at the beat of complex musical rhythms.~The intervention takes place in small groups of infant-caregiver pairs (N=4/5) for 1 hour/week for 6 weeks.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Passive auditory stimulation
Description: The same auditory stimulation is provided to infants, but no active tasks are proposed. Children and caregiver are entertained with motor and cognitive tasks not related to the auditory stimuli presented. The intervention takes place in small groups of infant-caregiver pairs (N=4/5) for 1 hour/week for 6 weeks.
Study: NCT04951726

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Neostigmine
Description: cholinesterase inhibitor
Study: NCT05067582

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: L1-79
Description: tyrosine hydroxylase inhibitor
Study: NCT04951726

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Neostigmine
Description: cholinesterase inhibitor
Study: NCT04728035

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Irinotecan Liposome Injection
Description: Irinotecan Liposome Injection

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Irinotecan Liposome Injection
Description: Irinotecan Liposome Injection
Study: NCT04998266

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Performing following WHO (World Health Organization)
Description: The CLA group will perform exercises following WHO (World Health Organization) prescription

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Performing on their needs
Description: The IND group will perform strength, aerobic or flexibility exercises depending on their needs observed during the first assessment.
Study: NCT05629390

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lotilaner
Description: Lotilaner Ophthalmic Solution

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Vehicle Control
Description: Vehicle of TP-03 ophthalmic solution
Study: NCT05308888

Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: 18F-FDG PET-CT
Description: The 18F-FDG PET-CT will be performed in the nuclear medicine department of the CHU of Brest. For this exam, the administration of 2-3 MBq/kg of 18F-FDG (\[18F\]F-fluorodeoxyglucose) will be performed to the patient in a single intravenous injection.
Study: NCT05634551

Intervention type: BEHAVIORAL
Intervention: Questionnaires
Description: Participants will complete 5 questionnaires about any symptoms participants may be having, any anxiety and/or depression participants may be having, your preference in decision-making, and your expectations about your treatment. It should take about 30 minutes to complete all 5 questionnaires

Intervention type: BEHAVIORAL
Intervention: Interview
Description: The interview will last about 30-45 minutes. The interview will be conducted over the phone or remotely over Zoom or FaceTime (based on your preference)
Study: NCT05228431

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: XELOX
Description: Starting from the first day of radiotherapy (set as day 0), the patient received a total of 4 courses of XELOX chemotherapy on days -42, -21, 42, and 63, including oxaliplatin 130 mg/m2, intravenous administration, d1, repeat every 3 weeks; and capecitabine 1000mg/m2, twice daily, d1-d14, repeat every 3 weeks.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Capecitabine monotherapy
Description: During radiotherapy (Monday to Friday), capecitabine was administered at 1650 mg/m2/d, twice a day.

Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Radiation
Description: The TV is expanded by 6-7mm to form PTV1, and the CTV is expanded by 6-7mm to form PTV2. The dose of PTV1 was 50Gy/25 times/35 days, and the dose of PTV2 was 45Gy/25 times/35 days, 5 times/week for a total of 5 weeks.
Study: NCT05088785

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: FES
Description: \[18F\]FES PET imaging.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: FES
Description: \[18F\]FES PET imaging.
Study: NCT05441501

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: JNJ-80038114
Description: JNJ-80038114 will be administered.
Study: NCT05270681

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Movement to Music
Description: Participants will be educated on how to access prerecorded Move to Improve classes conducted by a professional dance instructor which will be accessible by computer or tablet 24/7 via a hyperlink. Classes last 45 minutes, and participants will be instructed to participate in the activity at least twice weekly, for 12 weeks. Each class uses movement to music combinations across different dance genres that build in intensity and sequence complexity, accompanied by music with faster beats, to encourage participants to achieve a moderate-vigorous level of physical and cognitive activity. Care partners will be present during each class to ensure safety and will also participate in the Move to Improve exercise program. The care partner and participant will be instructed to stand at a counter or behind a chair for safety during exercise.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Movement to Music
Description: Participants will be educated on how to access prerecorded Move to Improve classes conducted by a professional dance instructor which will be accessible by computer or tablet 24/7 via a hyperlink. Classes last 45 minutes, and participants will be instructed to participate in the activity at least twice weekly, for 12 weeks. Each class uses movement to music combinations across different dance genres that build in intensity and sequence complexity, accompanied by music with faster beats, to encourage participants to achieve a moderate-vigorous level of physical and cognitive activity. Care partners will be present during each class to ensure safety and will also participate in the Move to Improve exercise program. The care partner and participant will be instructed to stand at a counter or behind a chair for safety during exercise.
Study: NCT05790603

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Intervention group with PHD-Band
Description: The initial compression pressure was systolic blood pressure plus 10mmHg. Pressure will be released by 20mmHg and 40mmHg 1 hour and 2 hours respectively after the surgery and then the band will be removed after 3 hours if no bleeding occurs. The compression will continue if bleeding occurs.
Study: NCT05325879

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: VAGUS-NDT
Description: Neurodynamic test for vagus nerve

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: VAGUS-NDT
Description: Neurodynamic test for vagus nerve
Study: NCT04690543

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: z-plasty
Description: Z-plasty: It will be defined as a local transposition flap that will be used to improve the functional and cosmetic appearance of scars. It will be involved creating two triangular flaps of equal dimensions that will be transposed.

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: square flap
Description: Square flap: It will be defined as is another local transposition flap which will be used for release of contractures. Square will be marked on one side of the contracture, and two triangles will be marked on the other side, with the length of all the flaps equal, which will be then transposed.
Study: NCT05830487

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Low AGE diet with reduced energy and fat
Description: This group will be given a low AGE diet with reduced energy and fat,.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Energy and fat-reduced normal diet
Description: This group will be given a diet with reduced energy and fat, and AGE levels will not be interfered with
Study: NCT05072561

Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Sentinel lymph node scintigraphy
Description: During the surgery, right after the identification of the primary, 18-37 MBq of 99mTc-Nanocolloids in two ml will be injected at four peritumoral locations. After a brief waiting time (5-10'), the thoracic surgeon will perform the clinical intervention, including the lobectomy (the injection sites will be resected alongside the tumour) and lymphadenectomy, according to the best clinical practice. All the excised lymph nodes will be ex vivo counted using a gamma probe: those with a detectable activity (at least 10% of the hottest lymph node) will be considered as SLN. Thereafter, the mediastinum will be scanned using the gamma probe and a handheld gamma-camera (the latter will not be employed in case of robotic-assisted surgery); any further source of radioactivity will be investigated and, should further lymph nodes be identified, these will be also resected and classified in SLN or non-SLN, based on ex vivo activity.
Study: NCT04554277

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Biomarker guided therapy
Description: Guided therapy using sST-2 monitoring at the discharge from initial hospitalisation, 6, 12, 18 and 24 months of following.
Study: NCT05352893

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Imsidolimab high dose
Description: intravenous

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Imsidolimab low dose
Description: intravenous

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: intravenous
Study: NCT03980457

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Indego Exoskeleton
Description: Powered generated orthosis

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Standard Rehabilitation
Description: Standard Rehabilitation

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Standard Rehabilitation
Description: Standard Rehabilitation